ID rozhodnutia | ID návrhu | Stupeň | Typ rozhodnutia | Navrhovateľ | Zverejnené | Akcia |
---|---|---|---|---|---|---|
<< < 1 2 3 4 5 > >> | ||||||
R 8635 | 29738 | 1 | R_A1E | Instituto Grifols, S.A. | 15.11.2023 | Detaily |
R 8634 | 29737 | 1 | R_A1E | Instituto Grifols, S.A. | 15.11.2023 | Detaily |
R 8633 | 29736 | 1 | R_A1E | Pharmevid s.r.o. | 15.11.2023 | Detaily |
R 8632 | 29735 | 1 | R_A1E | Pharmevid s.r.o. | 15.11.2023 | Detaily |
R 8631 | 29734 | 1 | R_A1E | Pharmevid s.r.o. | 15.11.2023 | Detaily |
R 8630 | 29731 | 1 | R_A1E | Accord Healthcare Polska Sp.z.o.o. | 15.11.2023 | Detaily |
R 8629 | 29730 | 1 | R_A1E | Accord Healthcare Polska Sp.z.o.o. | 15.11.2023 | Detaily |
R 8628 | 29717 | 1 | R_A1E | CANDE s.r.o. | 15.11.2023 | Detaily |
R 8627 | 29713 | 1 | R_A1E | CANDE s.r.o. | 15.11.2023 | Detaily |
R 8626 | 29694 | 1 | R_A1E | Medreg s.r.o. | 15.11.2023 | Detaily |
R 8625 | 29693 | 1 | R_A1E | Medreg s.r.o. | 15.11.2023 | Detaily |
R 8624 | 29692 | 1 | R_A1E | Medreg s.r.o. | 15.11.2023 | Detaily |
R 8623 | 29652 | 1 | R_A1E | Medochemie LTD | 15.11.2023 | Detaily |
R 8622 | 29572 | 1 | R_A1E | Vivanta Generics s.r.o. | 15.11.2023 | Detaily |
R 8621 | 29431 | 1 | R_A1E | Zentiva k.s. | 15.11.2023 | Detaily |
R 8620 | 29430 | 1 | R_A1E | Zentiva k.s. | 15.11.2023 | Detaily |
R 8619 | 29358 | 1 | R_A1E | Zentiva k.s. | 15.11.2023 | Detaily |
R 8618 | 28113 | 1 | R_A1E | Zentiva k.s. | 15.11.2023 | Detaily |
R 8617 | 26973 | 1 | R_A1N | Novartis Europharm Limited | 15.10.2023 | Detaily |
R 8616 | 26972 | 1 | R_A1N | Novartis Europharm Limited | 15.10.2023 | Detaily |
R 8615 | 26971 | 1 | R_A1N | Novartis Europharm Limited | 15.10.2023 | Detaily |
R 8614 | 26970 | 1 | R_A1N | Novartis Europharm Limited | 15.10.2023 | Detaily |
R 8613 | 26969 | 1 | R_A1N | Novartis Europharm Limited | 15.10.2023 | Detaily |
R 8612 | 26968 | 1 | R_A1N | Novartis Europharm Limited | 15.10.2023 | Detaily |
R 8611 | 26974 | 1 | R_A1N | Novartis Europharm Limited | 15.10.2023 | Detaily |